Ligand Pharmaceuticals (LGND) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
1.21
1.84
2.46
3.09

Details

Expected EPS
1.497143
Actual EPS
N/A
Surprise EPS
-1.5
Surprise Percent
+100%

Description

Ligand Pharmaceuticals (LGND) will report earnings of for Q1 2026 on February 26, 2026.

0 Comments

Share your thoughts